Update search
Filter
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
NARROW
Format
Type
Country
Date
Availability
1-7 of 7
Keywords: Pharmaceuticals
Close
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Sort by
Teaching Notes
Alkem Laboratories: managing employee motivation during pandemics
Available to Purchase
Journal:
Teaching Notes
Teaching Notes (2022) 18 (5): 786–801.
Published: 25 August 2022
... Publishing Limited Licensed re-use rights only Employee motivation Maslow’s need hierarchy Pandemic Need theory Absenteeism COVID-19 Herzberg’s two-factor theory Pharmaceuticals Alkem Laboratories is a leading pharma major from India with a global footprint. At the break...
Teaching Notes
Palforzia: Valuing a Treatment for Peanut Allergy
Available to Purchase
Journal:
Teaching Notes
Teaching Notes 1–14.
Published: 07 August 2022
... of evaluating therapies and tools that can help. Two questions face Clemence Shiffrin, senior vice president for business development at Oakdale Pharmaceuticals, and her business development team in January 2020: First, how valuable is Palforzia, a new preventive drug from Aimmune Therapeutics? Second, what...
Teaching Notes
Genzyme: The Renvela Launch Decision
Available to Purchase
Journal:
Teaching Notes
Teaching Notes 1–14.
Published: 20 January 2017
...Tim Calkins; Lynn Harris Pharmaceutical company Genzyme has created a new drug, Renvela, which is a phosphate binder designed to be used primarily by patients with kidney failure. Renvela is a slightly different version of Genzyme's highly successful Renagel. Company executives must now decide how...
Teaching Notes
Reintroduce Thalidomide? (B)
Available to Purchase
Journal:
Teaching Notes
Teaching Notes 1–10.
Published: 20 January 2017
... Pharmaceuticals Patient Advocacy Non-Government Organizations Global Pharmaceuticals This case describes a regulatory challenge faced by New Jersey-based biopharmaceutical player Celgene beginning during the 1990s. At the time, the company was interested in marketing thalidomide to U.S...
Teaching Notes
Forecasting Denosumab
Available to Purchase
Journal:
Teaching Notes
Teaching Notes 1–15.
Published: 20 January 2017
... will customers react? A healthcare case: Denosumab is a particularly good case for a healthcare class or a pharmaceutical industry class. The molecule is very high profile in the industry. The analysis required to create the forecast highlights many of the complicated aspects of the industry...
Teaching Notes
Danaka Corporation: Growth Portfolio Management
Available to Purchase
Journal:
Teaching Notes
Teaching Notes 1–16.
Published: 20 January 2017
...—electronic, mechanical, photocopying, recording, or otherwise—without the permission of the Kellogg School of Management. Pharmaceuticals Exhibit 6: Agriculture Business Unit Project Financial Highlights ($ in millions) 2005...
Teaching Notes
Roche and Tamiflu®: Doing Business in the Shadow of Pandemic
Available to Purchase
Journal:
Teaching Notes
Teaching Notes 1–22.
Published: 20 January 2017
... not be fulfilled until the end of 2008. Well aware that today's avian flu might become a global pandemic comparable to the Spanish flu, Roche CEO Franz Humer had to decide how Roche should respond. While the pharmaceutical industry continued its research efforts on vaccines and medications, Tamiflu could play...
